Results 201 to 210 of about 6,939 (250)

Atosiban versus placebo in the treatment of threatened preterm birth between 30 and 34 weeks gestation: study protocol of the 4-year APOSTEL 8 follow-up. [PDF]

BMJ Open
van der Windt L, Klumper J, van Limburg Stirum EVJ, van 't Hooft J, van Wely M, van Wassenaer-Leemhuis AG, Pajkrt E, Oudijk MA, APOSTEL 8 Study Group.   +8 more
europepmc   +1 more source

In Silico Evaluation of Tocolytic Potential of Phytoconstituents in Five Herbs Traditionally used for Treatment of Preterm Labor

Uyi M Ogbeide, J. O. Agbaje
openalex   +2 more sources

Group B Streptococcus Intrapartum Prophylaxis Guidelines Adherence: A Perinatal Risk Management Issue [PDF]

, 2010
Hanson, Lisa, VandeVusse, Leona
core   +1 more source

Case Report: Case analysis and literature review of preeclampsia complicated by inevitable abortion progressing to HELLP syndrome with liver rupture and hemorrhage. [PDF]

Front Med (Lausanne)
Xing G, Lu Y, Sun X.
europepmc   +1 more source

Essential notes: impacted fetal head. [PDF]

BJA Educ
Baycroft A, Conti D, Sultan P.
europepmc   +1 more source

Effect of progesterone as maintenance tocolytic therapy on the prevention of recurrent preterm labor: a randomized clinical trial

, 2007
Hajieh Borna, Sedigheh Borna, Soghra Khazardoust, Sedigheh Hantoushzadeh, Noshin Sahabi   +4 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tocolytic Drugs

2023
Abstract Tocolytic agents are agents that inhibit uterine contraction and allow enough time for corticosteroids to help with lung maturation. They are administered in cases of premature labor between the 22nd and 34th weeks of gestational age.
Piotr Al-Jindi, Bethany Potere
openaire   +1 more source

Controversies in Tocolytic Therapy

Clinical Obstetrics and Gynecology, 1999
In general, tocolytic agents are effective in stopping uterine contractions and in temporarily delaying delivery. The benefit of stopping uterine contractions is dependent on the fetal status and gestational age. The rationale for stopping preterm labor is to improve neonatal outcome.
V L, Katz, R M, Farmer
openaire   +2 more sources

Pharmacokinetics of Tocolytic Agents

Clinical Pharmacokinetics, 2004
Tocolytic agents are drugs designed to inhibit contractions of myometrial smooth muscle cells. Such an effect has been demonstrated in vitro or in vivo for several pharmacological agents, including beta-adrenergic agonists, calcium channel antagonists, oxytocin antagonists, NSAIDs and magnesium sulfate. However, the aim of tocolysis is not only to stop
Vassilis, Tsatsaris, Dominique, Cabrol, Bruno, Carbonne   +2 more
openaire   +2 more sources